Indian regulations fail to monitor growing stem-cell use in clinics

Article Abstract:

The Indian government departments have failed to regulate the use of stem-cells in treating a wide range of diseases in both private and public clinics. The Indian Council of Medical Research (ICMR) and the Department of Biotechnology (DBT) are negotiating a single set of guidelines on stem-cell research that will ensure that there are sufficient checks and controls on clinical practice.

Government regulation (cont), Government domestic functions, Government regulation, Drugs, Laws, regulations and rules, Biotechnology industry, Biotechnology industries, Science and technology policy, Embryology, Human, Human embryology, Stem cell research

---

Indian scientists battle journal retraction

Article Abstract:

An investigation report on a high-profile case in India related to research on signalling pathways in the development of skin cancer, authored by Bhatnagar award winning scientist, Gopal Kundu and his colleagues is presented.

Company legal issue, Cases, Investigations, Newspapers, Skin cancer, Cancer researchers, Research fraud, Corrections (Periodicals), Kundu, Gopal, India. Ministry of Science and Technology

---

Similar abstracts:

• Abstracts: Nuclear deal riles India's researchers. Misspent energy. India's just desserts

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.